Share ownership QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 08:22:28 09/06/2026 pm IST			5-day change	1st Jan Change
14.30 ^USD	-1.14%		+10.80%	-48.44%

07/05	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
07/05	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT

Share class: QuidelOrtho Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	6,81,90,989	6,75,51,893 ( 99.06 %)	0	99.06 %

Major shareholders: QuidelOrtho Corporation

Name	Stocks	%	Valuation
BlackRock Advisors LLC 14.48 %	98,30,932	14.48 %	128 M $
Fidelity Management & Research Co. LLC 11.56 %	78,52,322	11.56 %	102 M $
Fidelity Management & Research Co. LLC 9.707 %	65,91,152	9.707 %	86 M $
T. Rowe Price Investment Management, Inc. 8.291 %	56,29,965	8.291 %	73 M $
Newtyn Management LLC 7.806 %	53,00,000	7.806 %	69 M $
Newtyn Management LLC 6.713 %	45,58,472	6.713 %	59 M $
Vanguard Portfolio Management LLC 5.938 %	40,31,768	5.938 %	52 M $
Rubric Capital Management LP 4.869 %	33,06,281	4.869 %	43 M $
Invesco Advisers, Inc. 4.591 %	31,17,469	4.591 %	41 M $
Vanguard Capital Management LLC 4.496 %	30,52,710	4.496 %	40 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	126.95%
Others	9.11%
State Street Corp.	4.1%
Silvercrest Asset Management Group, Inc.	1.31%
Individuals	1.17%
SEI Investments Co.	0.4%
Schweizerische Nationalbank	0.2%
Fifth Third Bancorp	0.08%
The Allstate Corp.	0.05%
Manulife Financial Corp.	0.04%
Governments	0.03%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	132.05%
Australia	4.43%
United Kingdom	3.18%
Individuals	1.17%
Canada	0.84%
Netherlands	0.46%
Monaco	0.36%
Switzerland	0.25%
Cayman Islands	0.24%
Ireland	0.2%
Norway	0.09%
Hong Kong	0.07%
Sweden	0.06%
Germany	0.03%
Japan	0.01%

Based on 1000 largest holdings

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.

Employees

6,500

Sector

Advanced Medical Equipment & Technology

More about the company